Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics

Out of stock

Price data last checked 34 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 34 days. Could come back at any time — we're watching for you.

Out of stock 34 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
28 April 2024

Similar Products You Might Like

The 2025-2030 World Outlook for Cystic Fibrosis Drugs
99% match

The 2025-2030 World Outlook for Cystic Fibrosis Drugs

Price unavailable
The 2011-2016 Outlook for Cystic Fibrosis Drugs in Asia & Oceana
98% match

The 2011-2016 Outlook for Cystic Fibrosis Drugs in Asia & Oceana

£325.00 02 Jul 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 25 Jun 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 25 Jun 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 23 Jun 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 22 Jun 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan

£495.00 25 Jun 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan

£495.00 25 Jun 2026
Cystic Fibrosis: Facts, Management and Advances
96% match

Cystic Fibrosis: Facts, Management and Advances

IntechOpen

£114.00 09 Jul 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 23 Jun 2026
Cystic Fibrosis: Heterogeneity and Personalized Treatment
96% match

Cystic Fibrosis: Heterogeneity and Personalized Treatment

IntechOpen

£119.00 10 Jul 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 15 Jul 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 15 Jul 2026
Congenital Cystic Lung Disease: Comprehensive Understanding of its Diagnosis and Treatment from Fetus to Childhood
95% match

Congenital Cystic Lung Disease: Comprehensive Understanding of its Diagnosis and Treatment from Fetus to Childhood

Springer

£65.21 08 Jul 2026
The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments for US Zip Codes
95% match

The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments for US Zip Codes

£490.00 25 Jun 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 13 Jul 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 13 Jul 2026